Market Cap | 807.70M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -226.3M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -6.00% |
Sales | -212.5M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -18.00% |
Dividend | 2.00% | Price/Book | 0.50 | EPS next 5Y | - | 52W High Chg | -37.00% |
Recommedations | - | Quick Ratio | 7.57 | Shares Outstanding | 1B | 52W Low Chg | - |
Insider Own | 3.67% | ROA | -10.50% | Shares Float | 1.02B | Beta | 1.36 |
Inst Own | 70.54% | ROE | -19.26% | Shares Shorted/Prior | -/- | Price | 0.63 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 369 | Target Price | - |
Oper. Margin | 113.41% | Earnings Date | Sep 17 | Volume | 22,789 | Change | 0.00% |
IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe. It firm prefers to invest between £0.050 million ($0.08 million) and £1.25 million ($2.01 million) with revenue up to £45 million ($71 million). IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Hong Kong S.A.R., Hong Kong and Melbourne, Australia.